RCUS
Arcus Biosciences Inc Earnings Dividend
$26.48
Earnings Summary
Revenue | $33Mn |
Net Profits | $-98Mn |
Net Profit Margins | -296.97% |
Arcus Biosciences Inc’s revenue jumped 26.92% since last year same period to $33Mn in the Q4 2025. On a quarterly growth basis, Arcus Biosciences Inc has generated 26.92% jump in its revenue since last 3-months.
Arcus Biosciences Inc’s net profit fell -4.26% since last year same period to $-98Mn in the Q4 2025. On a quarterly growth basis, Arcus Biosciences Inc has generated 27.41% jump in its net profits since last 3-months.
Arcus Biosciences Inc’s net profit margin jumped 17.86% since last year same period to -296.97% in the Q4 2025. On a quarterly growth basis, Arcus Biosciences Inc has generated 42.81% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -1.1 |
EPS Estimate Current Year | -1.1 |
Arcus Biosciences Inc’s earning per share (EPS) estimates for the current quarter stand at -1.1 - a 0% jump from last quarter’s estimates.
Arcus Biosciences Inc’s earning per share (EPS) estimates for the current year stand at -1.1.
Key Ratios
Earning Per Share (EPS) | 0 |
Arcus Biosciences Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Arcus Biosciences Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-12 | -1.1 | 0 | 100% |
